New stroke drug tested for safety and brain bleeding risk
NCT ID NCT04091945
Summary
This study tested a new drug called LT3001 for people who recently had an ischemic stroke (caused by a blocked blood vessel in the brain). The main goal was to check if the drug is safe and doesn't cause dangerous bleeding in the brain, compared to a placebo. It involved 24 patients who received treatment within 24 hours of their stroke symptoms starting.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chattanooga Center for Neurologic Research
Chattanooga, Tennessee, 37403, United States
-
China Medical University Hospital
Taichung, Taiwan
-
JFK Neuroscience Institute, JFK Medical Center
Edison, New Jersey, 08837, United States
-
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, Taiwan
-
Linkou Chang Gung Memorial Hospital
New Taipei City, Taiwan
-
Taichung Veterans General Hospital
Taichung, Taiwan
-
Taipei Medical University - Shuang Ho Hospital
New Taipei City, Taiwan
-
Taipei Veterans General Hospital
Taipei, Taiwan
-
The Ohio State University - Wexner Medical Center
Columbus, Ohio, 43210, United States
-
University of Kentucky Chandler Medical Center
Lexington, Kentucky, 40536, United States
Conditions
Explore the condition pages connected to this study.